Literature DB >> 17851537

Stress, depression, and neuroplasticity: a convergence of mechanisms.

Christopher Pittenger1, Ronald S Duman.   

Abstract

Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of neuronal adaptation, is disrupted in mood disorders and in animal models of stress. Here we provide an overview of the evidence that chronic stress, which can precipitate or exacerbate depression, disrupts neuroplasticity, while antidepressant treatment produces opposing effects and can enhance neuroplasticity. We discuss neuroplasticity at different levels: structural plasticity (such as plastic changes in spine and dendrite morphology as well as adult neurogenesis), functional synaptic plasticity, and the molecular and cellular mechanisms accompanying such changes. Together, these studies elucidate mechanisms that may contribute to the pathophysiology of depression. Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.

Entities:  

Mesh:

Year:  2007        PMID: 17851537     DOI: 10.1038/sj.npp.1301574

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  517 in total

1.  Ozone modulates the effects of imipramine on immobility in the forced swim test, and nonspecific parameters of hippocampal oxidative stress in the rat.

Authors:  Mmalebuso L Mokoena; Brian H Harvey; Douglas W Oliver; Christiaan B Brink
Journal:  Metab Brain Dis       Date:  2010-05-09       Impact factor: 3.584

2.  Environmental enrichment protects against the effects of chronic stress on cognitive and morphological measures of hippocampal integrity.

Authors:  Katie M Hutchinson; Katie J McLaughlin; Ryan L Wright; J Bryce Ortiz; Danya P Anouti; Agnieszka Mika; David M Diamond; Cheryl D Conrad
Journal:  Neurobiol Learn Mem       Date:  2012-01-14       Impact factor: 2.877

Review 3.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

Review 4.  Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Authors:  Daniel C Mathews; Ioline D Henter; Carlos A Zarate
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

Review 5.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

6.  The dynamic serotonin system of the maternal brain.

Authors:  Joseph S Lonstein
Journal:  Arch Womens Ment Health       Date:  2018-07-21       Impact factor: 3.633

Review 7.  Stress as necessary component of realistic recovery in animal models of experimental stroke.

Authors:  Frederick R Walker; Kimberley A Jones; Madeleine J Patience; Zidan Zhao; Michael Nilsson
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

Review 8.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

Review 9.  Plasticity of defensive behavior and fear in early development.

Authors:  Christoph P Wiedenmayer
Journal:  Neurosci Biobehav Rev       Date:  2008-11-27       Impact factor: 8.989

10.  A neural pathway controlling motivation to exert effort.

Authors:  Christophe D Proulx; Sage Aronson; Djordje Milivojevic; Cris Molina; Alan Loi; Bradley Monk; Steven J Shabel; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.